Rifampicin 60mg-Isoniazid 30mg Tablets tablets dispersible

البلد: أرمينيا

اللغة: الإنجليزية

المصدر: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

خصائص المنتج خصائص المنتج (SPC)
10-10-2017

العنصر النشط:

rifampicin, isoniazid

متاح من:

Lupin Limited

ATC رمز:

J04AM02

INN (الاسم الدولي):

rifampicin, isoniazid

جرعة:

60mg+ 30mg

الشكل الصيدلاني:

tablets dispersible

الوحدات في الحزمة:

(84/14x6/) in strip

نوع الوصفة الطبية :

Prescription

الوضع إذن:

Registered

تاريخ الترخيص:

2017-10-05

خصائص المنتج

                                Isoniazid/Rifampicin 3 0 mg/60 mg
WHOPAR Part 4
January 2013
Dispersible Tablets
(Lupin
Ltd),
TB184
Page 1 of 20
SUMMARY OF PRODUCT CHARACTERISTICS
Isoniazid/Rifampicin 3 0 mg/60 mg
WHOPAR Part 4
January 2013
Dispersible Tablets
(Lupin
Ltd),
TB184
Page 2 of 20
1.
NAME OF THE MEDICINAL PRODUCT
RIFAMPICIN 60 MG - ISONIAZID 30 MG TABLETS
_I Rifampicin –Isoniazid. This product is intended for use in
children. Nonetheless, safety information is _
_provided for adult health issues such as liver disease, pregnancy and
lactation, to allow full access to all _
_relevant information. _
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each dispersible tablet contains:
Isoniazid 30 mg Rifampicin 60 mg
Each tablet also contains:
Aspartame 2 mg
Ponceau 4R (cochineal red A) 150 micrograms For a
full list of excipients see 6.1
3.
PHARMACEUTICAL FORM
Brick-red, flat-faced, bevel-edged, mottled, circular uncoated tablet
with break-line on one side and plain
on other side with characteristic flavour.
The break-line is for decorative purposes and not to divide the tablet
into equal doses.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Rifampicin 60 mg - Isoniazid 30 mg is indicated for the treatment of
tuberculosis in children, caused by
Mycobacterium tuberculosis, according to the guidelines of WHO
(Treatment of Tuberculosis: guidelines
4th edition, WHO, available at:
http://whqlibdoc.who.int/publications/2010/9789241547833_eng.pdf
Also, Rapid Advice, Treatment of Tuberculosis in Children, 2010,
available at:
http://whqlibdoc.who.int/publications/2010/9789241500449_eng.pdf
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Oral use.
CHILD'S WEIGHT DOSE (SINGLE DAILY DOSE)
5-7 kg
1 tablet daily
8-14 kg
2 tablets daily
15-20 kg 3 tablets daily
Children weighing over 20 kg should be treated with products
containing higher amounts of the drugs.
(See General references below.)
The required number of Rifampicin 60 mg - Isoniazid 30 mg should be
dispersed in approximately 50 ml
water and the entire mixture should be swallowed. The mixture (table
                                
                                اقرأ الوثيقة كاملة
                                
                            

مستندات بلغات أخرى

نشرة المعلومات نشرة المعلومات الروسية 10-10-2017

تنبيهات البحث المتعلقة بهذا المنتج